CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS DEFICIT - 12 months ended Mar. 31, 2024 - USD ($)	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated other comprehensive loss
Balance, shares at Mar. 31, 2023		60,000,000
Balance, amount at Mar. 31, 2023	$ (124,762)	$ 600	$ 442,828	$ (563,910)	$ (4,280)
Cancellation of common stock from related party, shares		36,865,000
Cancellation of common stock from related party, amount	0	$ (369)	369	0	0
Issuance of common stock for conversion of convertible note, shares		600,000
Issuance of common stock for conversion of convertible note, amount	30,000	$ 6	29,994	0	0
Issuance of common stock for conversion of convertible note one, shares		220,000
Issuance of common stock for conversion of convertible note one, amount	$ 11,000	$ 2	10,998	0	0
Issuance of common stock for deferred business acquisition cost, shares	369	12,550,000
Issuance of common stock for deferred business acquisition cost, amount	$ 161,895	$ 126	161,769	0	0
Other comprehensive loss	(3,625)	0	0	0	(3,625)
Net loss	(539,041)	$ 0	0	(539,041)	0
Balance, shares at Mar. 31, 2024		36,505,000
Balance, amount at Mar. 31, 2024	$ (464,533)	$ 365	$ 645,958	$ (1,102,951)	$ (7,905)